Key references: Ulcer and wound infection

  • Angel DE, Morey P, Storer JG, Mqipatayi BP. The great debate over iodine in wound care continues: a review of the literature. Wound Prac Res 2008;16(1):6–21.
  • Australian Wound Management Association Inc. Bacterial impact on wound healing: from contamination to infection [position paper]. Version 1.5. West Leederville, WA: AMWA; 2011.
  • Berendt AR, Peters EJ, Bakker K, Embil JM, Eneroth M, Hinchliffe RJ, et al. Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. Diabetes Metab Res Rev 2008;24 Suppl 1:S145–61. www.ncbi.nlm.nih.gov/pubmed/18442163
  • Davies CE, Hill KE, Newcombe RG, Stephens P, Wilson MJ, Harding KG, et al. A prospective study of the microbiology of chronic venous leg ulcers to reevaluate the clinical predictive value of tissue biopsies and swabs. Wound Repair Regen 2007;15(1):17–22. www.ncbi.nlm.nih.gov/pubmed/17244315
  • Dryden MS. Complicated skin and soft tissue infection. J Antimicrob Chemother 2010;65 Suppl 3:iii35–44. www.ncbi.nlm.nih.gov/pubmed/20876627
  • Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database Syst Rev 2017;6:CD011038. www.ncbi.nlm.nih.gov/pubmed/28613416
  • Howell-Jones RS, Wilson MJ, Hill KE, Howard AJ, Price PE, Thomas DW. A review of the microbiology, antibiotic usage and resistance in chronic skin wounds. J Antimicrob Chemother 2005;55(2):143–9. www.ncbi.nlm.nih.gov/pubmed/15649989
  • International Wound Infection Institute (IWII). Wound infection in clinical practice. London: Wounds International; 2016. http://www.woundinfection-institute.com/resources/
  • Jones V, Grey JE, Harding KG. Wound dressings. BMJ 2006;332(7544):777–80. www.ncbi.nlm.nih.gov/pubmed/16575081
  • Kramer A, Dissemond J, Kim S, Willy C, Mayer D, Papke R, et al. Consensus on wound antisepsis: pudate 2018. Skin Pharmacol Physiol 2018;31(1):28–58. www.ncbi.nlm.nih.gov/pubmed/29262416
  • Lindsay D, von Holy A. Bacterial biofilms within the clinical setting: what healthcare professionals should know. J Hosp Infect 2006;64(4):313–25. www.ncbi.nlm.nih.gov/pubmed/17046102
  • Lipsky BA, Aragon-Sanchez J, Diggle M, Embil J, Kono S, Lavery L, et al. IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Diabetes Metab Res Rev 2016;32 Suppl 1:45–74. www.ncbi.nlm.nih.gov/pubmed/26386266
  • Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, et al. Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012 2012 ;54(12):e132–73. www.ncbi.nlm.nih.gov/pubmed/22619242
  • Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004;39(7):885–910. www.ncbi.nlm.nih.gov/pubmed/15472838
  • Lipsky BA, Hoey C. Topical antimicrobial therapy for treating chronic wounds. Clin Infect Dis 2009;49(10):1541–9. www.ncbi.nlm.nih.gov/pubmed/19842981
  • Livesley NJ, Chow AW. Infected pressure ulcers in elderly individuals. Clin Infect Dis 2002;35(11):1390–6. www.ncbi.nlm.nih.gov/pubmed/12439803
  • Martin JM, Zenilman JM, Lazarus GS. Molecular microbiology: new dimensions for cutaneous biology and wound healing. J Invest Dermatol 2010;130(1):38–48. www.ncbi.nlm.nih.gov/pubmed/19626034
  • National Institute for Health and Care Excellence (NICE). Chronic wounds: advanced wound dressings and antimicrobial dressings. London: NICE; 2016. nice.org.uk/guidance/esmpb2
  • O'Meara S, Al-Kurdi D, Ologun Y, Ovington LG, Martyn-St James M, Richardson R. Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev 2014;(1):CD003557. www.ncbi.nlm.nih.gov/pubmed/24408354
  • O'Meara S, Richardson R, Lipsky BA. Topical and systemic antimicrobial therapy for venous leg ulcers. JAMA 2014;311(24):2534–5. www.ncbi.nlm.nih.gov/pubmed/25058087
  • Powlson AS, Coll AP. The treatment of diabetic foot infections. J Antimicrob Chemother 2010;65 Suppl 3:iii3–9. www.ncbi.nlm.nih.gov/pubmed/20876626
  • Smith DM, Snow DE, Rees E, Zischkau AM, Hanson JD, Wolcott RD, et al. Evaluation of the bacterial diversity of pressure ulcers using bTEFAP pyrosequencing. BMC Med Genomics 2010;3:41. www.ncbi.nlm.nih.gov/pubmed/20854691
  • Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 2014;59(2):e10–52. https://www.ncbi.nlm.nih.gov/pubmed/24973422
  • Storm-Versloot MN, Vos CG, Ubbink DT, Vermeulen H. Topical silver for preventing wound infection. Cochrane Database Syst Rev 2010;(3):CD006478. www.ncbi.nlm.nih.gov/pubmed/20238345
  • Vermeulen H, van Hattem JM, Storm-Versloot MN, Ubbink DT. Topical silver for treating infected wounds. Cochrane Database Syst Rev 2007;(1):CD005486. www.ncbi.nlm.nih.gov/pubmed/17253557
  • Watanabe K, Shimo A, Tsugawa K, Tokuda Y, Yamauchi H, Miyai E, et al. Safe and effective deodorization of malodorous fungating tumors using topical metronidazole 0.75 % gel (GK567): a multicenter, open-label, phase III study (RDT.07.SRE.27013). Support Care Cancer 2016;24(6):2583–90. www.ncbi.nlm.nih.gov/pubmed/26715293
  • Silver dressings--do they work? Drug Ther Bull 2010;48(4):38–42. www.ncbi.nlm.nih.gov/pubmed/20392779